Articles producció científica> Medicina i Cirurgia

DNA methylation pattern of hypertriglyceridemic subjects. [Patrón de metilación en ADN de sujetos hipertrigliceridémicos]

  • Dades identificatives

    Identificador: imarina:9242295
    Autors:
    Guardiola MIbarretxe DPlana NMasana LRibalta J
    Resum:
    Background: Chylomicronemias are generally diagnosed genetically by genomic sequencing or screening for mutations in causal genes with a large phenotypic effect. This strategy has allowed to improve the characterization of these patients, but we still have 30% of the patients without a conclusive genetic diagnosis. This is why we hypothesize that by adding the epigenetic component we can improve the genetic diagnosis, and for this we have explored the degree of methylation in the DNA of hypertriglyceridemic patients. Methodology: Blood cell DNA was obtained from 16 hypertriglyceridemic patients and from 16 age- and sex-matched control subjects. The degree of methylation in genome-wide DNA was determined using the Illumina® Infinium Methylation EPIC Array Analysis. Results: We identified 31 differentially methylated cytosines by comparing the methylation patterns presented by hypertriglyceridemic patients vs. control subjects. The cg03636183 in the F2RL3 gene was 10% hypomethylated in hypertriglyceridemic patients, and has previously been associated with an increased cardiovascular risk. Cg13824500 is 10% hypomethylated in hypertriglyceridemic patients and is located in VTI1A, which is a limiting gene in the transit of chylomicrons in the enterocyte through the endoplasmic reticulum and the Golgi apparatus. Cg26468118 in the RAB20 gene (13% hypomethylated) and cg21560722 in the SBF2 gene (33% hypermethylated) are involved in the regulation of Golgi apparatus vesicles. Conclusions: Our results suggest that there are differentially methylated regions related to the formation of chylomicrons in hypertriglyceridemic patients. © 2021 Sociedad Española de Arteriosclerosis
  • Altres:

    Autor segons l'article: Guardiola M; Ibarretxe D; Plana N; Masana L; Ribalta J
    Departament: Medicina i Cirurgia
    Autor/s de la URV: Guardiola Guionnet, Montserrat / Ibarretxe Gerediaga, Daiana / Masana Marín, Luis / Plana Gil, Núria / Ribalta Vives, Josep
    Paraules clau: Triglycerides Epigenome Dna methylation triglycerides smoking f2rl3 methylation epigenome association
    Resum: Background: Chylomicronemias are generally diagnosed genetically by genomic sequencing or screening for mutations in causal genes with a large phenotypic effect. This strategy has allowed to improve the characterization of these patients, but we still have 30% of the patients without a conclusive genetic diagnosis. This is why we hypothesize that by adding the epigenetic component we can improve the genetic diagnosis, and for this we have explored the degree of methylation in the DNA of hypertriglyceridemic patients. Methodology: Blood cell DNA was obtained from 16 hypertriglyceridemic patients and from 16 age- and sex-matched control subjects. The degree of methylation in genome-wide DNA was determined using the Illumina® Infinium Methylation EPIC Array Analysis. Results: We identified 31 differentially methylated cytosines by comparing the methylation patterns presented by hypertriglyceridemic patients vs. control subjects. The cg03636183 in the F2RL3 gene was 10% hypomethylated in hypertriglyceridemic patients, and has previously been associated with an increased cardiovascular risk. Cg13824500 is 10% hypomethylated in hypertriglyceridemic patients and is located in VTI1A, which is a limiting gene in the transit of chylomicrons in the enterocyte through the endoplasmic reticulum and the Golgi apparatus. Cg26468118 in the RAB20 gene (13% hypomethylated) and cg21560722 in the SBF2 gene (33% hypermethylated) are involved in the regulation of Golgi apparatus vesicles. Conclusions: Our results suggest that there are differentially methylated regions related to the formation of chylomicrons in hypertriglyceridemic patients. © 2021 Sociedad Española de Arteriosclerosis
    Àrees temàtiques: Pharmacology (medical) Peripheral vascular disease Medicina iii Medicina i Cardiology and cardiovascular medicine
    Adreça de correu electrònic de l'autor: daiana.ibarretxe@urv.cat montse.guardiola@urv.cat luis.masana@urv.cat josep.ribalta@urv.cat
    Identificador de l'autor: 0000-0002-9696-7384 0000-0002-0789-4954 0000-0002-8879-4719
    Data d'alta del registre: 2024-09-07
    Versió de l'article dipositat: info:eu-repo/semantics/acceptedVersion
    Enllaç font original: https://www.sciencedirect.com/science/article/abs/pii/S0214916821001352?via%3Dihub
    URL Document de llicència: https://repositori.urv.cat/ca/proteccio-de-dades/
    Referència a l'article segons font original: Clinica E Investigacion En Arteriosclerosis. 34 (1): 27-32
    Referència de l'ítem segons les normes APA: Guardiola M; Ibarretxe D; Plana N; Masana L; Ribalta J (2022). DNA methylation pattern of hypertriglyceridemic subjects. [Patrón de metilación en ADN de sujetos hipertrigliceridémicos]. Clinica E Investigacion En Arteriosclerosis, 34(1), 27-32. DOI: 10.1016/j.arteri.2021.09.002
    DOI de l'article: 10.1016/j.arteri.2021.09.002
    Entitat: Universitat Rovira i Virgili
    Any de publicació de la revista: 2022
    Tipus de publicació: Journal Publications
  • Paraules clau:

    Cardiology and Cardiovascular Medicine,Peripheral Vascular Disease,Pharmacology (Medical)
    Triglycerides
    Epigenome
    Dna methylation
    triglycerides
    smoking
    f2rl3 methylation
    epigenome
    association
    Pharmacology (medical)
    Peripheral vascular disease
    Medicina iii
    Medicina i
    Cardiology and cardiovascular medicine
  • Documents:

  • Cerca a google

    Search to google scholar